Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

Share Price is delayed by 15 minutes
Get Live Data
194.00    0.00 (0.00%)
Bid:
190.00
Ask:
198.00
Spread: 8.00 (4.211%)
Market Cap: £3.60m
NBB Live PriceLast checked at - London Stock Exchange

Intraday Norman Broadb Share Chart

Subscription

22 Oct 2013 07:00

NORMAN BROADBENT PLC - Subscription

NORMAN BROADBENT PLC - Subscription

PR Newswire

London, October 21

22 October 2013 Norman Broadbent plc ("Norman Broadbent" or "the Company") Fundraising to accelerate New Business Ventures Norman Broadbent is pleased to announce that it has raised £700,000 (the"Subscription") through the issue of 1,750,000 new ordinary shares in thecapital of the Company at a price of 40 pence per share (the "SubscriptionShares") principally to existing institutional investors. The Subscription isconditional upon admission of the Subscription Shares to trading on AIM("Admission"). The proceeds of the Subscription will be utilised primarily toaccelerate the growth of Arcus Global Partners ("Arcus") and ConnectingCorporates, the two new complementary business ventures established by theCompany at the beginning of the year. Arcus and Connecting Corporates, which operate in the growth areas of nichecontingent recruitment, interim and social media consultancy, have bothdelivered encouraging revenue growth with strong momentum since establishmentand in the directors' opinion have the hallmarks of developing into profitable,scalable and exportable businesses. The Subscription proceeds will enable theCompany to grow Arcus and Connecting Corporates quicker than originallyplanned, through the accelerated hiring of key personnel and by developingeffective technology-driven processes to support the growth. Application will be made for the Subscription Shares to be admitted to tradingon AIM with Admission expected to become effective on 25 October 2013.Following Admission the Company will have 14,798,686 ordinary shares in issue. Pierce Casey, Chairman of Norman Broadbent, commented: "The directors have been encouraged by how receptive the market has been to theflexible recruitment solutions offered by these new business ventures andbelieve that with this additional investment and the continued support of theestablished Group, the new businesses can achieve greater scale andprofitability more quickly." Contacts: Norman Broadbent plc 020 7484 0000Pierce Casey / Sue O'Brien / Ben Felton Sanlam Securities UK Limited (Nominated Adviser & 020 7628 2200Broker)Simon Clements / Virginia Bull / Catherine Miles Notes to Editors Norman Broadbent plc is a group of leading human capital consultancybusinesses. It offers board and executive search and leadership consultancyservices through Norman Broadbent, interim management, executive RPO andcontingent solutions through Arcus Global Partners and social media consultingand recruitment services through Connecting Corporates. Headquartered inLondon, the group operates globally and has offices in cities across Europe andin Bogota, Dubai, Los Angeles and Singapore.

For further information visit www.normanbroadbent.com

Date   Source Headline
20th May 202610:40 amRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
8th May 20267:00 amRNSDirectorate Change
28th Apr 20265:25 pmRNSCourt Approval of Capital Reduction
22nd Apr 20267:00 amRNSPosting of Annual Report & Notice of AGM
21st Apr 20267:00 amRNSQ1 2026 Trading Update
20th Apr 20267:00 amRNSDirectorate Change
31st Mar 20269:11 amRNSTotal Voting Rights
26th Mar 20262:00 pmRNSResult of General Meeting
25th Mar 20267:00 amRNSFinal Results
18th Mar 20268:00 amRNSHolding(s) in Company
10th Mar 20267:00 amRNSProposed Capital Reduction
9th Mar 20269:23 amRNSReplacement- Results Notice/Investor Presentation
9th Mar 20267:00 amRNSNotice of Interim Results & Investor Presentation
25th Feb 20267:00 amRNSAcquisition And Total Voting Rights
6th Feb 20267:03 amRNSDirectorate Change
21st Jan 20267:00 amRNSDirectorate Change
15th Jan 20267:00 amRNSQ4 and FY25 Trading Update
13th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSChange of Auditor
8th Sep 20257:00 amRNSInterim Results
19th Aug 20257:00 amRNSNotice of Interim Results & Investor Presentation
11th Aug 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
10th Jul 20257:00 amRNSH1 2025 Trading Update
19th Jun 20252:49 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
22nd May 202512:58 pmRNSResult of AGM, Capital Reorganisation and TVR
22nd May 20257:00 amRNSAGM Statement
22nd Apr 20257:00 amRNSPosting of ARA & Notice of AGM
2nd Apr 20257:00 amRNSQ1 2025 Trading Update and Final Results
4th Mar 20257:00 amRNSNotice of Results & Investor Presentation
16th Jan 20257:00 amRNSTrading Update
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.